Newsroom
Latest News
The House of Representatives on Thursday passed sweeping legislation that is poised to alter the sprawling landscape of Olympic sports, including giving more power to athletes and forcing more oversight of the coaches and executives who have traditionally controlled the sports.
Congress passed a bill Thursday that aims to protect Olympic athletes from abuse.
The Empowering Olympic, Paralympic, and Amateur Athletes Act of 2020 gives Congress the power to decertify both the U.S. Olympic and Paralympic Committee and the governing bodies for individual sports. It calls for more funding for the U.S. Center for SafeSport, the nonprofit that polices sexual abuse in Olympic Sports; confidentiality for whistleblowers that come forward to report abuse; and for more athletes on governing bodies.
The U.S. House of Representatives on Tuesday passed a bill to reauthorize and fund the U.S. Anti-Doping Agency, the organization that provides drug testing and education for the United States Olympic & Paralympic Committee and other sporting organizations.
On Wednesday, Sept. 30, 2020 at 11:30am ET, the House Energy and Commerce Oversight and Investigations Subcommittee - chaired by U.S. Rep. Diana DeGette (D-CO) – will hold a hearing entitled, "Pathway to a Vaccine: Ensuring a Safe and Effective Vaccine People Will Trust."
Livestream
WASHINGTON, D.C. – The U.S. House of Representatives today approved legislation to provide the U.S. Anti-Doping Agency the funding and tools it needs to ensure the world's top athletes are able to compete on a level playing field when the Olympics returns to the United States in 2028.
The bill – introduced by U.S. Rep. Diana DeGette (D-CO) – will fund the anti-doping agency through 2029, ensuring the agency has the resources it needs to prepare for, and oversee, the 2028 Games in Los Angeles.
Over the years, there have been numerous challenges in the way the United States has approached reproductive health. We rely on our public health institutions to make decisions using the best data to get the best outcomes. Twenty years ago, the Food and Drug Administration (FDA) approved mifepristone, the pill for medication abortion with numerous restrictions on who could prescribe the medication, where it could be taken and where it could be dispensed.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), who serves as co-chair of the Congressional Pro-Choice Caucus, released the following statement on the nomination of Amy Coney Barrett to be Associate Justice of the Supreme Court:
"Just because Judge Barrett is a woman doesn't mean she's a champion of women's rights. In fact, Judge Barrett has a long history of opposing women's constitutional right to reproductive care and to control what happens to their own body.
Three House Democrats are questioning the Environmental Protection Agency's (EPA) decision to postpone a training that was part of a series on environmental inequity faced by communities of color and low-income communities last month.
The EPA's decision to put off the event came in response to a White House memo telling agencies to "cease and desist from using taxpayer dollars to fund...divisive, un-American propaganda training sessions."